IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,721 | -42.5% | 2,563 | -38.2% | 0.00% | – |
| Q2 2023 | $197,882 | +94.6% | 4,145 | +60.4% | 0.00% | – |
| Q1 2023 | $101,680 | +195.3% | 2,584 | +112.3% | 0.00% | – |
| Q4 2022 | $34,429 | -32.5% | 1,217 | -27.9% | 0.00% | – |
| Q3 2022 | $51,000 | -15.0% | 1,689 | -3.0% | 0.00% | – |
| Q2 2022 | $60,000 | -93.7% | 1,742 | -91.7% | 0.00% | – |
| Q1 2022 | $945,000 | -14.3% | 21,076 | -11.7% | 0.00% | – |
| Q4 2021 | $1,103,000 | +82.6% | 23,866 | +32.8% | 0.00% | – |
| Q3 2021 | $604,000 | +1532.4% | 17,968 | +1337.4% | 0.00% | – |
| Q2 2021 | $37,000 | -78.9% | 1,250 | -81.6% | 0.00% | – |
| Q1 2021 | $175,000 | -53.5% | 6,802 | -58.8% | 0.00% | – |
| Q4 2020 | $376,000 | -6.0% | 16,496 | -11.7% | 0.00% | – |
| Q3 2020 | $400,000 | -27.1% | 18,690 | -21.0% | 0.00% | – |
| Q2 2020 | $549,000 | +110.3% | 23,648 | +93.0% | 0.00% | – |
| Q1 2020 | $261,000 | -10.3% | 12,254 | -1.6% | 0.00% | – |
| Q4 2019 | $291,000 | +14.6% | 12,448 | +3.1% | 0.00% | – |
| Q3 2019 | $254,000 | +8.5% | 12,077 | +5.9% | 0.00% | – |
| Q2 2019 | $234,000 | -33.1% | 11,402 | -8.3% | 0.00% | – |
| Q1 2019 | $350,000 | -50.6% | 12,435 | -57.1% | 0.00% | – |
| Q4 2018 | $709,000 | +581.7% | 28,970 | +942.8% | 0.00% | – |
| Q3 2018 | $104,000 | +447.4% | 2,778 | +199.0% | 0.00% | – |
| Q2 2018 | $19,000 | +171.4% | 929 | +85.8% | 0.00% | – |
| Q1 2018 | $7,000 | -12.5% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +60.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -81.0% | 500 | -79.3% | 0.00% | – |
| Q1 2017 | $21,000 | +31.2% | 2,418 | +72.6% | 0.00% | – |
| Q4 2016 | $16,000 | -33.3% | 1,401 | 0.0% | 0.00% | – |
| Q3 2016 | $24,000 | +700.0% | 1,401 | +809.7% | 0.00% | – |
| Q1 2016 | $3,000 | -50.0% | 154 | -23.8% | 0.00% | – |
| Q4 2015 | $6,000 | – | 202 | +1022.2% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 18 | -87.2% | 0.00% | – |
| Q2 2015 | $3,000 | – | 141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |